Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
International Journal of Clinical Oncology|September 29, 2021
Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative studyTomokazu Aoki, Naoki Kagawa, Kazuhiko Sugiyama, et al.
Acta Neuropathologica Communications|September 25, 2023
Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group studyKohei Fukuoka, Jun Kurihara, Tomoko Shofuda, et al.
Plos One|December 3, 2020
Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasionTakamune Achiha, Noriyuki Kijima, Yoshinori Kodama, et al.
International Journal of Cancer|May 13, 2016
Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptideYusuke Oji, Naoya Hashimoto, Akihiro Tsuboi, et al.
Neuro-Oncology|November 4, 2024
Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up studyHirokazu Takami, Masao Matsutani, Tomonari Suzuki, et al.
Cancers|January 21, 2023
WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1Yusuke Oji, Naoki Kagawa, Hideyuki Arita, et al.
Acta Neuropathologica Communications|July 26, 2024
Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohortNobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, et al.
Neuro-Oncology Advances|August 6, 2021
Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversyMasayuki Kanamori, Hirokazu Takami, Tomonari Suzuki, et al.
Neuro-Oncology|August 21, 2020
So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?Masayuki Kanamori, Hirokazu Takami, Shigeru Yamaguchi, et al.
Acta Neuropathologica Communications|August 10, 2016
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomasHideyuki Arita, Kai Yamasaki, Yuko Matsushita, et al.
Pageof 11